IndraLab

Statements


BRAF binds KRAS and NRAS. 7 / 7
| 7

sparser
"At present, KRAS , NRAS , and BRAF mutations are associated with poorer outcomes in metastatic CRC, both in surgical and nonsurgical patients."

sparser
"We now show the MAPK-ERK genes, BRAF, KRAS and NRAS (collectively representing 12.2% of patients) are also independently associated with short OS in a cohort of patients requiring treatment."

sparser
"The detection of a KRAS, NRAS or BRAF gene mutation was associated with a trend towards shorter overall survival compared to when no mutations were detected by the MS test (Figure xref )."

sparser
"Studies have identified several genetic alterations, including KRAS, NRAS and BRAF mutations, which are associated with resistance to anti-EGFR agents."

sparser
"The detection of a KRAS, NRAS or BRAF gene mutation was associated with a trend toward shorter duration of benefit from EGFR-TKI treatment compared to when no mutations were detected by the MS test (Figure xref )."

sparser
"KRAS, NRAS, and BRAF mutations are associated with sensitivity to MEK inhibitors, but EGFR mutations are not (Fig.  xref c)."

sparser
"The eighth edition of the AJCC Cancer Staging System is focused on the individual treatment and prognostic factors of CRC based on molecular biomarkers, such as BRAF , KRAS , and NRAS that are associated with chromosomal instability, mismatch repair, and microsatellite instability [ xref ]."